The Estimation on the Innovation Performance of Manufacture of Medicines of China Based on the DEA-Benchmarking Model
As an important high technology industry,Manufacture of medicines is developing fast and has a bright future.This paper presents an empirical analysis and a systemic evaluation on the manufacture of medicines innovation performance in China based on the provincial panel data of 2008 by using the DEA-Benchmarking model.Moreover,we try to show the feasibility and superiority for evaluating innovation performance using DEA-Benchmarking model based on the practical examples through comparing the results generated from different methods.
DEA model Manufacture of medicines Innovation performance Benchmarking management
Chong ZHANG Qinliang TAN
Renewable Energy School and State Key Laboratory of Alternate Electrical Power System with Renewable Economics and Management School North China Electric Power University Beijing,China
国际会议
青岛
英文
684-689
2012-07-20(万方平台首次上网日期,不代表论文的发表时间)